Fox Jonathan C 4
4 · Edgewise Therapeutics, Inc. · Filed Jun 14, 2023
Insider Transaction Report
Form 4
Fox Jonathan C
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-12+22,123→ 22,123 totalExercise: $9.55From: 2024-06-12Exp: 2033-06-12→ Common Stock (22,123 underlying)
Footnotes (1)
- [F1]100% of the Stock Options granted on June 12, 2023 will become vested on the earlier of (i) June 12, 2024 or (ii) the business day prior to the date of the 2024 annual meeting of stockholders.